Medical instruments and supplies stocks with the highest profit margins

Ranked

80

of 137 medical instruments and supplies stocks we cover

Median

−2.3%

Highest

57.6%

LNSR

Range

−84.9% to 57.6%

#	Company	Net margin	Operating margin	Revenue growth (TTM)	Market cap
1	LNSRLENSAR	57.6%	−13.5%	+3.3%	$74.6M
2	RMDResMed	26.9%	33.4%	+9.9%	$36.5B
3	IRMDIradimed	26.7%	31.9%	+11.2%	$1.1B
4	ISRGIntuitive Surgical	25.5%	28.4%	+20.5%	$159.8B
5	LMATLemaitre Vascular	25.0%	29.5%	+11.8%	$1.9B
6	PDEXPro DEX	17.6%	16.8%	+16.4%	$199.3M
7	SOLVSolventum	17.3%	25.0%	−0.9%	$14.5B
8	GMEDGlobus Medical	17.0%	20.3%	+19.7%	$10.9B
9	WSTWest Pharmaceutical Services	17.0%	20.5%	+12.4%	$27.6B
10	MSAMSA Safety	16.1%	21.2%	+6.5%	$7B
11	INSPInspire Medical Systems	15.0%	6.0%	+4.3%	$2.1B
12	BMIBadger Meter	14.3%	18.6%	−2.2%	$4.4B
13	COOCooper Companies	13.5%	12.8%	+4.7%	$11.6B
14	PODDInsulet	12.3%	16.9%	+29.4%	$10.3B
15	UFPTUFP Technologies	11.4%	15.3%	+7.3%	$2.3B
16	VNTVontier	11.3%	18.8%	+0.9%	$4.6B
17	PENPenumbra	10.7%	12.4%	+17.6%	$12.8B
18	ALGNAlign Technology	10.0%	13.2%	+4.4%	$11B
19	BVSBioventus	9.4%	10.0%	+3.1%	$1.3B
20	MMSIMerit Medical Systems	9.2%	12.8%	+10.2%	$5.6B
21	EMBCEmbecta	8.6%	21.9%	−7.6%	$380.2M
22	HAEHaemonetics	7.1%	11.9%	+0.4%	$5.4B
23	TCMDTactile Systems Technology	7.1%	10.0%	+17.2%	$535.5M
24	APTAlpha Pro Tech	6.8%	7.5%	+5.7%	$56.7M
25	MOVMovado	6.0%	6.9%	+5.2%	$701.9M
26	INFUInfuSystem	6.0%	9.3%	+2.5%	$277.6M
27	CDRECadre	5.3%	10.1%	+19.7%	$1.3B
28	BDXBecton, Dickinson and	4.5%	9.6%	+5.2%	$54.2B
29	NVSTEnvista	3.3%	9.6%	+11.9%	$3.8B
30	KEQUKewaunee Scientific	3.0%	5.4%	+5.3%	$94.9M
31	EYENational Vision	2.5%	4.1%	+7.8%	$1.5B
32	ATRCAtriCure	1.9%	2.3%	+13.9%	$3B
33	MDXGMimedx	1.8%	2.5%	−2.4%	$569.9M
34	ICUIICU Medical	1.4%	3.3%	−9.0%	$4.2B
35	STAAStaar Surgical	1.1%	4.0%	+51.3%	$1.1B
36	WRBYWarby Parker	0.8%	0.2%	+11.0%	$3.2B
37	DCTHDelcath Systems	0.6%	−1.9%	+35.8%	$500.4M
38	IARTIntegra Lifesciences	−0.4%	4.0%	+0.8%	$926.3M
39	AORTArtivion	−0.7%	4.4%	+16.4%	$1.1B
40	IRTCiRhythm	−1.7%	−3.0%	+25.6%	$4B
41	CERSCerus	−2.9%	−0.7%	+16.2%	$469.6M
42	ANIKAnika Therapeutics	−3.1%	−4.2%	+5.3%	$286.7M
43	BLCOBausch & Lomb	−3.2%	6.1%	+8.9%	$6.2B
44	TNDMTandem Diabetes Care	−6.1%	−4.4%	+4.0%	$1.2B
45	SIBNSI-BONE	−6.9%	−8.3%	+15.3%	$962.7M
46	INGNInogen	−6.9%	−8.7%	+3.2%	$188.4M
47	FOSLFossil	−7.1%	−0.6%	−9.1%	$390.3M
48	OFIXOrthofix Medical	−7.4%	−4.7%	+3.0%	$399.6M
49	BAXBaxter International	−9.3%	−2.4%	+5.4%	$13.1B
50	SKINSkinHealth Systems	−9.8%	−1.5%	−6.5%	$70.8M
51	ANGOAngiodynamics	−10.1%	−11.2%	+8.2%	$520M
52	XTNTXtant Medical	−10.2%	−9.6%	−14.3%	$39.6M
53	ARAYAccuray	−12.2%	−6.6%	−12.3%	$15.5M
54	ATECAlphatec	−13.5%	−6.0%	+19.5%	$1.7B
55	LAKELakeland Industries	−14.0%	−4.1%	−0.3%	$95.2M
56	APYXApyx Medical	−14.8%	−6.1%	+25.6%	$99.8M
57	XRAYDENTSPLY SIRONA	−15.0%	−8.5%	−0.8%	$1.9B
58	KIDSOrthopediatrics	−15.7%	−11.9%	+14.5%	$639.7M
59	ESTAEstablishment Labs	−15.8%	−7.6%	+38.6%	$1.9B
60	NPCENeuroPace	−19.3%	−15.3%	+16.9%	$443.1M
61	STIMNeuronetics	−19.6%	−14.7%	+39.6%	$160.8M
62	NVCRNovoCure	−21.2%	−22.1%	+11.0%	$1.7B
63	SSIISS Innovations International	−23.7%	−16.2%	+89.7%	$450.9M
64	TMCITreace Medical Concepts	−29.0%	−26.2%	−4.0%	$277.7M
65	SMTISanara MedTech	−29.2%	7.7%	+13.0%	$301.4M
66	GKOSGLAUKOS	−30.7%	−31.6%	+41.5%	$10.6B
67	PRCTPROCEPT BioRobotics	−32.5%	−33.9%	+22.7%	$1.1B
68	SGHTSight Sciences	−35.7%	−33.4%	+9.3%	$495.2M
69	RXSTRxSight	−36.8%	−43.2%	−13.2%	$208.8M
70	OSUROrasure Technologies	−43.7%	−48.1%	−18.9%	$284.8M
71	TFXTeleflex	−45.8%	2.0%	+30.7%	$5.8B
72	ENOVEnovis CORP	−48.0%	−45.1%	+4.9%	$1.2B
73	TELATELA Bio	−51.5%	−42.6%	+6.1%	$43.3M
74	LUNGPulmonx	−55.0%	−53.0%	−3.4%	$78.6M
75	HTFLHeartflow	−55.8%	−37.8%	+42.8%	$4.9B
76	RCELAVITA Medical	−57.0%	−46.6%	+1.0%	$479.7M
77	CARLCarlsmed	−57.4%	−61.1%	+65.4%	$396.7M
78	SIShoulder Innovations	−58.3%	−58.5%	+60.9%	$409.3M
79	BBNXBeta Bionics	−61.3%	−69.8%	+52.5%	$862M
80	CVRXCVRx	−84.9%	−79.5%	+12.0%	$37.8M

Not ranked: 24 with a margin moved by items that are not sales, 15 with under $50M of revenue, 7 with a quarter missing, 2 with not a meaningful number, 1 with no margin to measure. 8 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.